T cell Response in Q fever (TRIQ-study)

T cell Response in Q fever (TRIQ-study) - TRIQ-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35925

Enrollment

Registered

2011-05-23

Start date

2011-11-24

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q fever

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -history of Q fever =/> 6 months: clinically compatible illness with serologically proven Coxiella burnetii infection. -10 Q fever patients, no sequelae -10 QFS patients (diagnosis: CFS as diagnosed using the 1994 CDC criteria) -10 chronic Q fever patients -10 seronegative controls -informed consent

Exclusion criteria

Exclusion criteria: - clinically significant co-morbidity (not for chronic Q fever patients) - immunosuppressive medication -

Design outcomes

Primary

Measure	Time frame
Results of the Coxiella ELISPOT assay for the different Q fever outcome groups.	—

Countries

Netherlands

Outcome results